Physician profile
Imran Qureshi
NPI 1487604161
$3,276.56
in general payments reported to CMS, 2019-2025
19 companies · $432 in 2025
The $432 reported for 2025 was more than what 78% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $693 · 2020: $281 · 2021: $359 · 2022: $806 · 2023: $466 · 2024: $238 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $740.61 | 2019-2025 | Spinejack, Flowtriever, Avaflex |
| Inari Medical, INC. | $409.58 | 2022 | |
| Medtronic USA, INC. | $408.62 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $371.05 | 2019-2021 | |
| Medtronic, INC. | $316.93 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Concertotm, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $206.77 | 2020-2025 | Eluvia, Ekosonic, Obsidio |
| Lexicon Pharmaceuticals, INC. | $191.89 | 2023-2024 | Inpefa |
| Abbott Laboratories | $125.42 | 2020-2025 | Proclaim |
| Astrazeneca Pharmaceuticals LP | $124.24 | 2024 | Farxiga |
| Abiomed | $86.18 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.22 | 2025 | Jardiance |
| Abbvie INC. | $45.61 | 2023 | |
| Cardinal Health 414 LLC | $45.42 | 2023 | |
| Terumo Medical Corporation | $35.32 | 2022 | |
| Cardiva Medical, INC. | $25.09 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $21.30 | 2023 | Illuccix |
| Davol INC. | $17.96 | 2023 | Venovo |
| Janssen Pharmaceuticals, INC | $16.23 | 2024 | Xarelto |
| Siemens Medical Solutions USA, INC. | $16.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.